Skip to Main Content

Author Details

Peng Jiang
Anhui Medical University
1997
85
40
Ying Ding (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34669962UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species.Nucleic Acids Res2022
36230928Tracing Translational Footprint by Ribo-Seq: Principle, Workflow, and Applications to Understand the Mechanism of Human Diseases.Cells2022
35251990Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA.Front Oncol2022
34669962UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species.Nucleic Acids Res2022
35262677Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer.Clin Cancer Res2022
36230928Tracing Translational Footprint by Ribo-Seq: Principle, Workflow, and Applications to Understand the Mechanism of Human Diseases.Cells2022
35251990Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA.Front Oncol2022
35262677Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer.Clin Cancer Res2022
33323402Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.Clin Cancer Res2021
33707234CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.Cancer Discov2021
33589424Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.Cancer Discov2021
34209818Toward a Coronavirus Knowledge Graph.Genes (Basel)2021
34150612Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.Front Oncol2021
33323402Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.Clin Cancer Res2021
34594031Systematic investigation of cytokine signaling activity at the tissue and single-cell levels.Nat Methods2021
33707234CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.Cancer Discov2021
33589424Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.Cancer Discov2021
34594031Systematic investigation of cytokine signaling activity at the tissue and single-cell levels.Nat Methods2021
34209818Toward a Coronavirus Knowledge Graph.Genes (Basel)2021
34150612Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis.Front Oncol2021
32413516CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma.Genomics Proteomics Bioinformatics2020
32413516CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma.Genomics Proteomics Bioinformatics2020
33381115Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors.Front Immunol2020
32728046An integrative ENCODE resource for cancer genomics.Nat Commun2020
33059736Clonal tracing reveals diverse patterns of response to immune checkpoint blockade.Genome Biol2020
32723834Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors.Clin Cancer Res2020
33059736Clonal tracing reveals diverse patterns of response to immune checkpoint blockade.Genome Biol2020
33381115Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors.Front Immunol2020
32728046An integrative ENCODE resource for cancer genomics.Nat Commun2020
32723834Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors.Clin Cancer Res2020
31038666kmcEx: memory-frugal and retrieval-efficient encoding of counted k-mers.Bioinformatics2019
31038666kmcEx: memory-frugal and retrieval-efficient encoding of counted k-mers.Bioinformatics2019
30742113Landscape of B cell immunity and related immune evasion in human cancers.Nat Genet2019
31101897Publisher Correction: Landscape of B cell immunity and related immune evasion in human cancers.Nat Genet2019
31440271Efficient Mining of Variants From Trios for Ventricular Septal Defect Association Study.Front Genet2019
31440271Efficient Mining of Variants From Trios for Ventricular Septal Defect Association Study.Front Genet2019
31101897Publisher Correction: Landscape of B cell immunity and related immune evasion in human cancers.Nat Genet2019
30742113Landscape of B cell immunity and related immune evasion in human cancers.Nat Genet2019
29301958A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Science2018
29868757Improved design and analysis of CRISPR knockout screens.Bioinformatics2018
30127393Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.Nat Med2018
29987050Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.Proc Natl Acad Sci U S A2018
29301958A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Science2018
29428415Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.Cell Syst2018
31342013Big Data Approaches for Modeling Response and Resistance to Cancer Drugs.Annu Rev Biomed Data Sci2018
30127393Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.Nat Med2018
29987050Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.Proc Natl Acad Sci U S A2018
29868757Improved design and analysis of CRISPR knockout screens.Bioinformatics2018
31342013Big Data Approaches for Modeling Response and Resistance to Cancer Drugs.Annu Rev Biomed Data Sci2018
29428415Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.Cell Syst2018
  • 1 - 50 of 170

Recommended Authors

University of Laval
Career Start Year 2007
Number of shared co-authors 0
Fondazione Istituto Italiano di Tecnologia
Career Start Year 2006
Number of shared co-authors 0
Indiana University
Career Start Year 2004
Number of shared co-authors 0
Osaka University
Career Start Year 2004
Number of shared co-authors 0
Center for Genomics and Systems Biology, New York University
Career Start Year 2003
Number of shared co-authors 0
University of Toronto
Career Start Year 2002
Number of shared co-authors 2
The China-Japan Union Hospital, Jilin University
Career Start Year 2002
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2002
Number of shared co-authors 3
University of Toronto
Career Start Year 2000
Number of shared co-authors 1
Institute of Biochemistry and Molecular Immunology, RWTH Aachen University
Career Start Year 2000
Number of shared co-authors 1
York University
Career Start Year 2000
Number of shared co-authors 0
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Career Start Year 1999
Number of shared co-authors 2
Smurfit Institute of Genetics, Trinity College of Dublin
Career Start Year 1999
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 5
Biomedicine Discovery Institute, Monash University
Career Start Year 1998
Number of shared co-authors 0
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 1998
Number of shared co-authors 2
Technical University of Denmark
Career Start Year 1995
Number of shared co-authors 2
Max Planck Institute of Molecular Plant Physiology
Career Start Year 1995
Number of shared co-authors 0
University of Lausanne
Career Start Year 1994
Number of shared co-authors 3
Peking-Tsinghua Center for Life Sciences, College of Life Sciences, Peking University
Career Start Year 1994
Number of shared co-authors 2
Aix Marseille University, CNRS, Turing Center for Living Systems
Career Start Year 1993
Number of shared co-authors 1
Pacific Northwest National Laboratory
Career Start Year 1993
Number of shared co-authors 1
University of Toronto
Career Start Year 1992
Number of shared co-authors 2
University of Massachusetts Medical School
Career Start Year 1992
Number of shared co-authors 4
University of Cologne
Career Start Year 1991
Number of shared co-authors 0
Princess Maxima Center for Pediatric Oncology
Career Start Year 1990
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 1990
Number of shared co-authors 0
Institute for Advanced Biosciences, Keio University
Career Start Year 1988
Number of shared co-authors 1
RIKEN Center for Integrative Medical Sciences
Career Start Year 1985
Number of shared co-authors 2
Princess Maxima Center for Pediatric Oncology Research
Career Start Year 1983
Number of shared co-authors 0

Collaborators

Co-authored papers 23
Center for the Development of Therapeutics, Broad Institute of MIT and Harvard
Co-authored papers 16
Co-authored papers 10
Co-authored papers 7
Co-authored papers 6
Co-authored papers 5
Center for Public Health Genomics, University of Virginia
Co-authored papers 5
Co-authored papers 4
College of Plant Protection, Southwest University
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Huaihe Hospital of Henan University
Co-authored papers 1
Yale University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University Health Network, University Health Network and University of Toronto
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Co-authored papers 1